579 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Rank Status Study
21 Recruiting Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Tubal Carcinoma;   Primary Peritoneal Carcinoma
Intervention: Radiation: intensity-modulated whole-abdominal radiotherapy
22 Recruiting ONSD According to the Position During Laparoscopy
Conditions: Cholecystitis;   Ovarian Cyst;   Ovarian Cancer;   Uterine Myoma;   Cervical Cancer
Interventions: Drug: Desflurane;   Drug: Remifentanil;   Device: Ultrasonographic measurement of ONSD;   Procedure: Mechanical ventilation;   Procedure: Trendelenburg position - 30 degree;   Procedure: Reverse Trendelenburg position - 30 degree
23 Unknown  Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma
Conditions: Epithelial Ovarian Carcinoma;   Figo Stage IIIC
Intervention: Procedure: hyper thermic chemo + surgery
24 Recruiting Ovarian Dendritic Cell Vaccine Trial
Condition: Ovarian Cancer
Interventions: Biological: Ontak DC;   Biological: DC vaccination;   Drug: Ontak
25 Recruiting Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
Conditions: Malignant Solid Tumour;   Breast Cancer;   Malignant Tumor of Colon;   GIST;   Ovarian Cancer
Intervention: Biological: HER-2 vaccine
26 Not yet recruiting Gut Microbiome in Patients With Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome
Intervention: Behavioral: diet
27 Recruiting DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
Conditions: Stage IA Fallopian Tube Cancer;   Stage IA Ovarian Epithelial Cancer;   Stage IA Primary Peritoneal Cavity Cancer;   Stage IB Fallopian Tube Cancer;   Stage IB Ovarian Epithelial Cancer;   Stage IB Primary Peritoneal Cavity Cancer;   Stage IC Fallopian Tube Cancer;   Stage IC Ovarian Epithelial Cancer;   Stage IC Primary Peritoneal Cavity Cancer;   Stage IIA Fallopian Tube Cancer;   Stage IIA Ovarian Epithelial Cancer;   Stage IIA Primary Peritoneal Cavity Cancer;   Stage IIB Fallopian Tube Cancer;   Stage IIB Ovarian Epithelial Cancer;   Stage IIB Primary Peritoneal Cavity Cancer;   Stage IIC Fallopian Tube Cancer;   Stage IIC Ovarian Epithelial Cancer;   Stage IIC Primary Peritoneal Cavity Cancer;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Primary Peritoneal Cavity Cancer
Interventions: Biological: DEC-205/NY-ESO-1 fusion protein CDX-1401;   Drug: poly ICLC;   Drug: IDO1 inhibitor INCB024360;   Other: pharmacological study;   Other: laboratory biomarker analysis
28 Unknown  Stress, Immunity and Cervical Cancer: Biobehavioral Outcomes
Condition: Ovarian Cancer
Interventions: Behavioral: Telephone counseling;   Behavioral: Telephone interview
29 Unknown  Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
Conditions: Breast Cancer;   Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer;   Prostate Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Interventions: Genetic: gene expression analysis;   Genetic: gene rearrangement analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Radiation: radiation therapy
30 Recruiting Time Course of Waking Versus Sleep-associated Luteinizing Hormone (LH) Pulse Frequency Suppression in Response to Progesterone in Late Pubertal Girls With and Without Hyperandrogenemia
Condition: Hyperandrogenemia
Interventions: Drug: Micronized progesterone suspension;   Drug: Placebo
31 Unknown  Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer
Conditions: brca1 Mutation Carrier;   brca2 Mutation Carrier;   Ovarian Cancer
Interventions: Other: diagnostic laboratory biomarker analysis;   Other: liquid chromatography;   Other: mass spectrometry;   Procedure: screening method
32 Unknown  A Controlled Study of Quality of Life and it's Related Factors Among Gynecological Cancer Survivors
Conditions: Cervical Cancer;   Ovarian Cancer;   Endometrial Cancer
Intervention:
33 Unknown  A Survivorship Care Plan for Gynaecological Cancer Patients
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Cervical Cancer;   Endometrial Cancer;   Esophageal Cancer;   Fallopian Tube Cancer;   Gastric Cancer;   Ovarian Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Intervention:
34 Recruiting A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Interventions: Drug: Gemcitabine;   Drug: pazopanib
35 Recruiting Comparison Between the Role of Follicular Output Rate and Preovulatory Count in the Prediction of Pregnancy in Women With Polycystic Ovarian Syndrome Undergoing Intra Cytoplasmic Sperm Injection (ICSI)
Conditions: Polycystic Ovarian Syndrome;   Subfertility;   ICSI
Intervention:
36 Unknown  Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
Conditions: Hyperandrogenemia;   Obesity;   Polycystic Ovary Syndrome
Interventions: Drug: Hydrocortisone;   Drug: dexamethasone;   Drug: Cosyntropin (ACTH)
37 Recruiting Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.
Conditions: Ovarian Cancer;   Cervical Cancer;   Uterine Cancer;   Anemia
Interventions: Other: Oral Ferrous Fumarate;   Other: Placebo
38 Recruiting Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis
Conditions: Polycystic Ovary Syndrome;   Disorder of Glucose Regulation
Interventions: Drug: Metformin XR;   Drug: Saxagliptin;   Drug: Saxagliptin-Metformin XR
39 Unknown  Study of Circulating Tumoral DNA in Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Other: Blood sampling
40 Unknown  [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer
Condition: Ovarian Neoplasm
Intervention: Drug: Pazopanib and paclitaxel

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years